Literature DB >> 28339644

Development and validation of a structured query language implementation of the Elixhauser comorbidity index.

Richard H Epstein1, Franklin Dexter2.   

Abstract

OBJECTIVE: Comorbidity adjustment is often performed during outcomes and health care resource utilization research. Our goal was to develop an efficient algorithm in structured query language (SQL) to determine the Elixhauser comorbidity index.
MATERIALS AND METHODS: We wrote an SQL algorithm to calculate the Elixhauser comorbidities from Diagnosis Related Group and International Classification of Diseases (ICD) codes. Validation was by comparison to expected comorbidities from combinations of these codes and to the 2013 Nationwide Readmissions Database (NRD).
RESULTS: The SQL algorithm matched perfectly with expected comorbidities for all combinations of ICD-9 or ICD-10, and Diagnosis Related Groups. Of 13 585 859 evaluable NRD records, the algorithm matched 100% of the listed comorbidities. Processing time was ∼0.05 ms/record. DISCUSSION: The SQL Elixhauser code was efficient and computationally identical to the SAS algorithm used for the NRD.
CONCLUSIONS: This algorithm may be useful where preprocessing of large datasets in a relational database environment and comorbidity determination is desired before statistical analysis. A validated SQL procedure to calculate Elixhauser comorbidities and the van Walraven index from ICD-9 or ICD-10 discharge diagnosis codes has been published.
© The Author 2017. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  algorithms; comorbidity; computing methodologies; software validation

Mesh:

Year:  2017        PMID: 28339644      PMCID: PMC7651966          DOI: 10.1093/jamia/ocw181

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  12 in total

1.  Identifying patients with severe hospital-acquired infections due to Staphylococcus aureus by using the Healthcare Cost and Utilization Project (HCUP): problems and pitfalls.

Authors:  C Souvignet; G Frebourg; L Baril
Journal:  Infect Control Hosp Epidemiol       Date:  2004-06       Impact factor: 3.254

2.  Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.

Authors:  Danielle A Southern; Hude Quan; William A Ghali
Journal:  Med Care       Date:  2004-04       Impact factor: 2.983

3.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

4.  Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis.

Authors:  Kelli L Dominick; Tara K Dudley; Cynthia J Coffman; Hayden B Bosworth
Journal:  Arthritis Rheum       Date:  2005-10-15

5.  Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality.

Authors:  George Mnatzaganian; Philip Ryan; Paul E Norman; Janet E Hiller
Journal:  J Clin Epidemiol       Date:  2011-07-31       Impact factor: 6.437

6.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

7.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

8.  Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality.

Authors:  Haifeng Zhu; Michael D Hill
Journal:  Neurology       Date:  2008-07-22       Impact factor: 9.910

9.  The effects of preexisting medical comorbidities on mortality and length of hospital stay in acute burn injury: evidence from a national sample of 31,338 adult patients.

Authors:  Brett D Thombs; Vijay A Singh; Jill Halonen; Alfa Diallo; Stephen M Milner
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

10.  Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.

Authors:  Bing Li; Dewey Evans; Peter Faris; Stafford Dean; Hude Quan
Journal:  BMC Health Serv Res       Date:  2008-01-14       Impact factor: 2.655

View more
  4 in total

1.  Using UMLS for electronic health data standardization and database design.

Authors:  Andrew P Reimer; Alex Milinovich
Journal:  J Am Med Inform Assoc       Date:  2020-10-01       Impact factor: 4.497

2.  The influence of heart failure on clinical and economic outcomes among older adults ≥75 years of age with acute myocardial infarction.

Authors:  Swetha Pasala; Lauren B Cooper; Mitchell A Psotka; Shashank S Sinha; Christopher R deFilippi; Henry Tran; Behnam Tehrani; Matthew Sherwood; Kelly Epps; Wayne Batchelor; Abdulla A Damluji
Journal:  Am Heart J       Date:  2021-12-16       Impact factor: 4.749

3.  Toolkit to Compute Time-Based Elixhauser Comorbidity Indices and Extension to Common Data Models.

Authors:  Shorabuddin Syed; Ahmad Baghal; Fred Prior; Meredith Zozus; Shaymaa Al-Shukri; Hafsa Bareen Syeda; Maryam Garza; Salma Begum; Kim Gates; Mahanazuddin Syed; Kevin W Sexton
Journal:  Healthc Inform Res       Date:  2020-07-31

4.  Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis.

Authors:  Abdulla A Damluji; Michael Fabbro; Richard H Epstein; Stefan Rayer; Ying Wang; Mauro Moscucci; Mauricio G Cohen; John D Carroll; John C Messenger; Jon R Resar; David J Cohen; Matthew W Sherwood; Christopher M O'Connor; Wayne Batchelor
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.